Characteristics of dry eye disease in patients with autoimmune diseases
Pediatric ocular surface reconstruction: Managing lesion excision challenges
This population requires careful attention from diagnosis through the entire postoperative process.
Potential biomarkers of primary open-angle glaucoma in patient serum in Nigeria
When the world went virtual: How ophthalmology’s conferences stayed on track
Five years after the COVID-19 pandemic shutdown reshaped how the world gathers, here's how some of ophthalmology’s leading associations are still applying lessons forged in crisis
Self-reported vision problems tied to increased sleep dysfunction in older adults
Researchers develop virus-like particle to enhance editing proteins causing inherited eye diseases
Regeneron announces FDA issues CRL for aflibercept 8 mg (Eylea HD) sBLA
The FDA did not agree with a supplemental Biologics License Application for the addition of extended dosing intervals of up to 24 weeks across currently-approved indications.
Prevent Blindness urges West Virginia State Legislature to reject bill removing newborn eye infection protection
The affected mandate requires that all newborns receive erythromycin ointment applied to their eyes after birth, which helps prevent ophthalmia neonatorum.
Unveiling genetic distinctions between reticular pseudodrusen and drusen
Insights from a genome-wide association study identify novel genetic loci
Zhaoke enrolls first patient in phase 3 trial of cyclosporine ophthalmic gel for dry eye
CsA Ophthalmic Gel is an innovative cyclosporine gel being developed by Zhaoke in China for the treatment of moderate to severe DED.
Using retinal images to classify metabolic syndrome
Authors defined metabolic syndrome as “the set of factors that increase the risk of cardiovascular disease and diabetes, such as hypertension, central obesity, insulin resistance, and atherogenic dyslipidemia.”
AI-assisted biomarker segmentation offers precision in nAMD disease monitoring
Authors of the study believe this potential will provide clinicians with valuable information about patient responses to treatment.
CIME 2025 unveils a galaxy of innovation in modern eye care
Neda Shamie, MD, previews the May 4 conference, where a faculty of ophthalmologists and optometrists will explore the latest advancements and controversies.
50 years of visionary innovation: Leading ophthalmologists reflect on the field’s greatest breakthroughs
Celebrating a half-century of progress with Ophthalmology Times.
Companies announce presentations at upcoming 2025 ARVO Annual Meeting
The annual ARVO meeting will be held in Salt Lake City, Utah and feature presentation on clinical trials from around the globe.
BVI Medical receives 510(k) FDA clearance for glaucoma surgical system
Leos is supported by emerging data from a randomized controlled clinical trial, further validating its safety and efficacy.
Regeneron’s sBLA for Eylea HD accepted for priority review by FDA
The sBLA seeks approval for Eylea HD for both the treatment of macular edema following retinal vein occlusion and broadening the dosing schedule to include every-4-week dosing across approved indications.
ISO issues new standards for presbyopia-correcting IOL classification
Updated guidelines characterize IOLs by functional performance over optical design.
Effect of race on visual outcomes in DME treated with ranibizumab
The research team noted that racial subgroups are underrepresented in clinical trials, a factor that should be addressed in future clinical trials.
FDA grants RMAT designation to Atsena Therapeutics' gene therapy for XLRS
ATSN-201 was given regenerative medicine advanced therapy designation to treat X-linked retinoschisis, for which there currently are no approved treatments.
Aflibercept: Applications for dosing duration and additional indications pending decision with FDA and EMA
A decision on a longer dosing duration for the high-dose formulation is expected by April 20, 2025.
Study finds knowledge gaps in public understanding of glaucoma and cataracts
A survey collected demographic data, ocular and medical history, and responses assessing knowledge of glaucoma and cataracts in the Qassim region of Saudi Arabia.
Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
Mah previews a packed 2025 Annual Meeting, from the debut of SightLine to Dr. Glaucomflecken’s return to the main stage, and outlines his priorities for the year ahead as incoming ASCRS president.
Biocon reaches settlement agreement with Regeneron to launch aflibercept biosimilar, Yesafili, in the US
This agreement allows a launch in the US in the second half of 2026 or earlier in certain circumstances.
Piecing it together: Does semaglutide fit the NAION puzzle?
Eyestem releases positive results from phase 1 trial in patients with geographic atrophy
Eyecyte-RPE is a suspension of human induced pluripotent stem cell–derived retinal pigment epithelial cells.
Impact of social media intervention on follow-up for patients with congenital ectopia lentis
Congenital ectopia lentis is a rare ocular disease characterized by the dislocation or displacement of the lens.
AI reading label system enhances retinal disease diagnosis and training in ophthalmology
In their study, 16 ophthalmologists, including attending physicians and residents with levels of experience ranging from 1 to 9 years, were included.
Nextech and Ocuco partner to deliver seamless end-to-end eyecare platform
The partnership will integrate Ocuco’s optical software solution, Acuitas 3, with Nextech’s Ophthalmic Platform.
Study finds geographic and institutional disparities for DR and DME clinical trials
Results showed an unequal distributions of these clinical trials among rural and low-income populations.
